📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Rational development of an attenuated recombinant cyprinid herpesvirus 3 vaccine using prokaryotic mutagenesis and in vivo bioluminescent imaging. (2015)

First Author: Boutier M

Attributed to: Persistent Infections funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1371/journal.ppat.1004690

PubMed Identifier: 25700279

Publication URI: http://europepmc.org/abstract/MED/25700279

Type: Journal Article/Review

Volume: 11

Parent Publication: PLoS pathogens

Issue: 2

ISSN: 1553-7366